BRUSSELS, Sept 25 (Reuters) - Belgian cancer diagnosis and therapy company Ion Beam Applications said on Thursday that it has signed a distribution deal with Korea's Hae Dong for its positron emission tomography (PET) radiopharmaceuticals.
Hae Dong will distribute IBA's radiopharmaceuticals to seven production centres in South Korea.
Hae Dong is a Korean market leader for radiation oncology products and nuclear medicine.
(Reporting by Antonia van de Velde) Keywords: IBA/ tf.TFN-Europe_newsdesk@thomson.com ak COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
Hae Dong will distribute IBA's radiopharmaceuticals to seven production centres in South Korea.
Hae Dong is a Korean market leader for radiation oncology products and nuclear medicine.
(Reporting by Antonia van de Velde) Keywords: IBA/ tf.TFN-Europe_newsdesk@thomson.com ak COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
© 2008 AFX News
